Drawing for TRIVERITAS

USPTO serial 88572827

TRIVERITAS

Reviewed by CopyMark Law Group

Reg. 6128217Status 700Renewal
Filing date
Status date
Registration date
Aug 18, 2020
Examiner
BHANOT, KAPIL KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRIVERITAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald E. Shapiro

Ronald E. Shapiro SHAPIRO AND SILVERSTEIN PLLC1300 PENNSYLVANIA AVENUE NW SUITE 700WASHINGTON, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Preparation of business expert reports relating to biological, biotechnology, pharmaceutical and veterinary mattersACTIVE—
036Financial appraisal of biological, biotechnology, pharmaceutical and veterinary research and development servicesACTIVE—
042Biological, biotechnology, pharmaceutical and veterinary research and development; conducting and developing clinical trials for others; providing quality assurance services in the field of biological, biotechnology, pharmaceutical and veterinary research and development services; Testing, analysis and evaluation of the services of others to determine conformity with certification standards; preparation of scientific expert reports relating to biological, biotechnology, pharmaceutical and veterinary mattersACTIVE—
045Advice and consultancy on regulatory matters in the fields of biological, biotechnology, pharmaceutical and veterinary research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 15, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 8, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 28, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 23, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2020ALIEASSIGNED TO LIE—
Apr 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2019GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 9, 2019GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 9, 2019EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Nov 9, 2019CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 8, 2019DOCKASSIGNED TO EXAMINER—
Aug 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance